CD8A and neoplasm: When antigen-presenting cells (APCs) acquire tumor antigens and damage-associated molecular patterns (DAMPs) from tumor cells undergoing ICD, they can present tumor antigen epitopes, upregulate costimulatory signals, and secrete cytokines for activation of antitumor T cells, especially cytotoxic CD8 + T cells5.